Zuckerman Investment Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-51,522
| Closed | -$1.31M | – | 163 |
|
|
2025
Q3 | $1.31M | Sell |
51,522
-58
| -0.1% | -$1.43K | 0.12% | 75 |
|
|
2025
Q2 | $1.25M | Sell |
51,580
-5,366
| -9% | -$125K | 0.12% | 74 |
|
|
2025
Q1 | $1.44M | Buy |
56,946
+34
| +0.1% | +$890 | 0.15% | 69 |
|
|
2024
Q4 | $1.49M | Sell |
56,912
-2,174
| -4% | -$59K | 0.14% | 69 |
|
|
2024
Q3 | $1.71M | Sell |
59,086
-6,978
| -11% | -$204K | 0.18% | 61 |
|
|
2024
Q2 | $1.85M | Sell |
66,064
-15,011
| -19% | -$413K | 0.21% | 57 |
|
|
2024
Q1 | $2.25M | Buy |
81,075
+38,210
| +89% | +$1.06M | 0.26% | 50 |
|
|
2023
Q4 | $1.23M | Buy |
42,865
+9,501
| +28% | +$287K | 0.16% | 63 |
|
|
2023
Q3 | $1.11M | Sell |
33,364
-4,000
| -11% | -$141K | 0.16% | 56 |
|
|
2023
Q2 | $1.37M | Buy |
37,364
+3,000
| +9% | +$117K | 0.2% | 53 |
|
|
2023
Q1 | $1.4M | Buy |
34,364
+4,000
| +13% | +$173K | 0.21% | 52 |
|
|
2022
Q4 | $1.56M | Hold |
30,364
| – | – | 0.25% | 53 |
|
|
2022
Q3 | $1.33M | Hold |
30,364
| – | – | 0.25% | 50 |
|
|
2022
Q2 | $1.59M | Sell |
30,364
-250
| -0.8% | -$12.7K | 0.29% | 52 |
|
|
2022
Q1 | $1.58M | Buy |
30,614
+152
| +0.5% | +$7.89K | 0.26% | 52 |
|
|
2021
Q4 | $1.8M | Buy |
30,462
+1,093
| +4% | +$54.2K | 0.28% | 53 |
|
|
2021
Q3 | $1.26M | Buy |
29,369
+57
| +0.2% | +$2.52K | 0.21% | 60 |
|
|
2021
Q2 | $1.15M | Buy |
29,312
+33
| +0.1% | +$1.28K | 0.18% | 60 |
|
|
2021
Q1 | $1.06M | Buy |
+29,279
| New | +$1.04M | 0.17% | 60 |
|
|
2015
Q3 | – | Sell |
-7,630
| Closed | -$243K | – | 49 |
|
|
2015
Q2 | $243K | Sell |
7,630
-323
| -4% | -$10.5K | 0.05% | 41 |
|
|
2015
Q1 | $263K | Sell |
7,953
-12,121
| -60% | -$385K | 0.06% | 48 |
|
|
2014
Q4 | $593K | Hold |
20,074
| – | – | 0.13% | 40 |
|
|
2014
Q3 | $563K | Sell |
20,074
-320
| -2% | -$8.98K | 0.12% | 45 |
|
|
2014
Q2 | $574K | Sell |
20,394
-1,235
| -6% | -$35.2K | 0.12% | 36 |
|
|
2014
Q1 | $659K | Sell |
21,629
-799
| -4% | -$23.8K | 0.16% | 27 |
|
|
2013
Q4 | $652K | Sell |
22,428
-211
| -0.9% | -$6.14K | 0.15% | 32 |
|
|
2013
Q3 | $617K | Buy |
22,639
+4,194
| +23% | +$114K | 0.15% | 33 |
|
|
2013
Q2 | $490K | Buy |
+18,445
| New | +$510K | 0.13% | 37 |
|
Other funds holding PFE
Zuckerman Investment Group's PFE Position: Q4 2025 in Review
Zuckerman Investment Group sold out of Pfizer (PFE) in Q4 2025, closing a stake of 51,522 shares — an estimated $1.31M sold.
Zuckerman Investment Group first reported a position in PFE in Q2 2013 and held it in 28 quarters. The position peaked at $2.25M in Q1 2024. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Zuckerman Investment Group reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Zuckerman Investment Group sold 51,522 Pfizer shares in Q4 2025, an estimated $1.31M.
- Zuckerman Investment Group first reported a position in Pfizer in Q2 2013 and held it in 28 quarters.
- Zuckerman Investment Group's Pfizer position peaked at $2.25M in Q1 2024.
- 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Zuckerman Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.